SEC FORM
4
SEC Form 4
FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0287 |
Estimated average burden |
hours per response: |
0.5 |
|
|
![](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABAAAAAQCAMAAAAoLQ9TAAAAQlBMVEUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACO4fbyAAAAFXRSTlMAAQQGCRgmLjAxODpeYX66xcro9/1q/ORJAAAAS0lEQVQYV83PuQGAIBQE0UFADuX299+qiaAl+LLZbAHrw2PXwFbkNRzkZpjUOTT9WA1KdsR9BiT8ZPDU9GkjlnglNx2tALGusz1v3P2eBcKAqrXpAAAAAElFTkSuQmCC) |
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
C/O TARGACEPT, INC. |
200 EAST FIRST STREET, SUITE 300 |
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
TARGACEPT INC
[ TRGT ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
3. Date of Earliest Transaction
(Month/Day/Year) 02/23/2007
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
Amount |
(A) or (D) |
Price |
Common Stock |
02/23/2007 |
|
M |
|
803 |
A |
$0.075
|
1,510,883 |
I |
By EuclidSR Partners, L.P.
|
Common Stock |
02/23/2007 |
|
M |
|
197 |
A |
$0.075
|
371,945 |
I |
By EuclidSR Biotechnology Partners, L.P.
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Stock Option (Right to Buy) |
$0.075
|
02/23/2007 |
|
M |
|
|
803 |
06/07/2006 |
|
Common Stock |
803 |
$0
|
0 |
I |
By EuclidSR Partners L.P.
|
Stock Option (Right to Buy) |
$0.075
|
02/23/2007 |
|
M |
|
|
197 |
06/07/2006 |
|
Common Stock |
197 |
$0
|
0 |
I |
By EuclidSR Biotechnology Partners L.P.
|
Explanation of Responses: |
Remarks: |
|
/s/ Peter A. Zorn, Attorney-in-Fact |
02/27/2007 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Unassociated Document
Securities
and Exchange Commission
Judiciary
Plaza
450
Fifth
Street, N.W.
Washington,
DC 20549
Re: Targacept,
Inc.
Gentlemen:
Pursuant
to General Instruction 7 to Form 3 (Initial Statement of Beneficial Ownership),
Form 4 (Statement of Changes in Beneficial Ownership) and Form 5 (Annual
Statement of Changes in Beneficial Ownership) promulgated by the Securities
and
Exchange Commission pursuant to Section 16 of the Securities Exchange Act of
1934, the undersigned director, officer and/or shareholder of Targacept, Inc.
(the “Company”) hereby authorizes and designates Peter A. Zorn, Mauri K. Hodges,
and Alan A. Musso, and each of them, to execute and file with the Commission
on
her behalf any and all statements on Form 3, Form 4 or Form 5 relating to her
beneficial ownership of securities of the Company as required by Section 16(a)
of the Securities Exchange Act of 1934 and the rules of the Commission
promulgated thereunder. This authorization and designation shall be effective
for so long as the undersigned remains subject to the provisions of Section
16
of the Securities Exchange Act of 1934.
Effective
as of July 18, 2006.
|
/s/
Elaine V. Jones
|
|
Elaine
V. Jones
|